StonvexLoading…
StonvexStonvexStonvexCore line items from ANVS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-29.70M | $-26.69M | $-45.04M | $-25.51M |
Net Income | $-28.85M | $-24.59M | $-56.20M | $-25.33M |
EPS (Diluted) | $-1.40 | $-2.31 | $-6.23 | $-3.10 |
Total Assets | $21.08M | $13.93M | $10.21M | $36.02M |
Total Liabilities | $4.23M | $4.62M | $17.96M | $7.70M |
Cash & Equivalents | $19.53M | $10.55M | $5.75M | $28.38M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 27.20M | 14.14M | 10.52M | 8.16M |